UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.976-988

2016

Volltextzugriff (PDF)

Precise and Ultrafast Molecular Sieving Through Graphene Oxide Membranes

Science (American Association for the Advancement of Science), 2014-02, Vol.343 (6172), p.752-754

2014

Volltextzugriff (PDF)

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Journal of clinical oncology, 2012-03, Vol.30 (8), p.863-870

2012

Volltextzugriff (PDF)

Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival

PloS one, 2023-02, Vol.18 (2), p.e0282206-e0282206

2023

Volltextzugriff (PDF)

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

PloS one, 2017-06, Vol.12 (6), p.e0178420

2017

Volltextzugriff (PDF)

DLL3: an emerging target in small cell lung cancer

Journal of hematology and oncology, 2019-06, Vol.12 (1), p.61-61, Article 61

2019

Volltextzugriff (PDF)

Van der Waals pressure and its effect on trapped interlayer molecules

Nature communications, 2016-07, Vol.7 (1), p.12168-12168, Article 12168

2016

Volltextzugriff (PDF)

Non–Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.974-984

2015

Volltextzugriff (PDF)

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

Clinical cancer research, 2016-05, Vol.22 (10), p.2396-2404

2016

Volltextzugriff (PDF)

Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC

Journal of thoracic oncology, 2020-11, Vol.15 (11), p.1773-1781

2020

Volltextzugriff (PDF)

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Cancer cell, 2004-10, Vol.6 (4), p.409-421

2004

Volltextzugriff (PDF)

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Cancer cell, 2008-01, Vol.13 (1), p.23-35

2008

Volltextzugriff (PDF)

EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19), p.5572-5584

2014

Volltextzugriff (PDF)

Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches

Annals of oncology, 2021-09, Vol.32 (9), p.1101-1110

2021

Volltextzugriff (PDF)

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.678-689

2001

Volltextzugriff (PDF)

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

BMC cancer, 2024-04, Vol.24 (1), p.424-424, Article 424

2024

Volltextzugriff (PDF)

Computational characterisation of dried and hydrated graphene oxide membranes

Nanoscale, 2018-01, Vol.10 (4), p.1946-1956

2018

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.946-963

2016

Volltextzugriff (PDF)

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial

The lancet oncology, 2016-12, Vol.17 (12), p.1661-1671

2016

Volltextzugriff (PDF)

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

Nature communications, 2018-08, Vol.9 (1), p.3198-16, Article 3198

2018

Volltextzugriff (PDF)

Adenosine receptors in regulation of dendritic cell differentiation and function

Blood, 2008-09, Vol.112 (5), p.1822-1831

2008

Volltextzugriff (PDF)

Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim

Oncogene, 2010-01, Vol.29 (4), p.589-596

2010

Volltextzugriff (PDF)

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

BMC cancer, 2019-04, Vol.19 (1), p.353-16, Article 353

2019

Volltextzugriff (PDF)

Multiscale modelling of heterogeneous fillers in polymer composites: the case of polyisoprene and carbon black

Journal of physics. Condensed matter, 2021-04, Vol.33 (19), p.194003

2021

Volltextzugriff (PDF)

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer

Cancer research (Chicago, Ill.), 2005, Vol.65 (1), p.226-235

2005

Volltextzugriff (PDF)

1 – 25 von 3.996

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.397)
Mit Volltextzugriff
(3.351)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(1.878)
MEDLINE
(1.578)
Ingenta
(1.414)
Publisher website
(1.108)
Journals@Ovid Full Text
(1.077)
Elsevier ScienceDirect Journals Complete
(754)
IngentaConnect Journals
(494)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(486)
Wiley-Blackwell Journals
(454)
Springer Nature - Complete Springer Journals
(392)
Wiley Online Library
(374)
American Physical Society Journals
(232)
IEEE Xplore
(183)
American Physical Society [PROLA]
(181)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(143)
Oxford Journals
(143)
Nature
(131)
JSTOR All Journals
(92)
Oxford Journals 2020 Medicine
(91)
SpringerLink Series
(84)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer

Precise and Ultrafast Molecular Sieving Through Graphene Oxide Membranes

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

DLL3: an emerging target in small cell lung cancer

Van der Waals pressure and its effect on trapped interlayer molecules

Non–Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling

Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

Computational characterisation of dried and hydrated graphene oxide membranes

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

Adenosine receptors in regulation of dendritic cell differentiation and function

Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Multiscale modelling of heterogeneous fillers in polymer composites: the case of polyisoprene and carbon black

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer

Suchergebnisse filtern